
Patients can interrupt treatment of immune-supressing medicines for two-weeks in order to boost immunity provided by COVID-19 booster vaccine, finds major study
A major clinical trial, supported by researchers at Manchester BRC, has shown that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their treatment for two weeks immediately after having the vaccine.
Continue reading full article: Patients can interrupt treatment of immune-supressing medicines for two-weeks in order to boost immunity provided by COVID-19 booster vaccine, finds major study